Andreas Rieckmann

Andreas Rieckmann

Contact

Andreas Rieckmann
T. +45 32689046 @. anri@ssi.dk

Research area 

Non-specific effects of vaccines; Child health; Causal inference, Complex epidemiology, Explanation of public health trends.

Publications

Benn CS, Fisker AB, Rieckmann A, Jensen AG, Aaby Peter. How to evaluate potential non-specific effects of vaccines: The quest for randomized trials or time for triangulation? Expert Review of Vaccines. 2018. Impact factor (2017): 4.271.

Rieckmann A, Tamason CC, Gurley ES, Rod NH, Jensen PKM. Exploring Droughts and Floods and Their Association with Cholera Outbreaks in Sub-Saharan Africa: A Register-Based Ecological Study from 1990 to 2010. Am. J. Trop. Med. Hyg. 2018 Mar 5. Impact factor (2017): 2.564.

Rieckmann A, Villumsen M, Jensen ML, Ravn H, da Silva ZJ, Sorup S, Baker JL, Rodrigues A, Benn CS, Roth AE, Aaby P. The Effect of Smallpox and Bacillus Calmette-Guérin Vaccination on the Risk of Human Immunodeficiency Virus-1 Infection in Guinea-Bissau and Denmark. Open Forum Infect Dis. 2017;4(3):ofx130. PMCID: PMC5569962. Impact factor (2018): 3.240.

Rieckmann A, Villumsen M, Sorup S, Haugaard LK, Ravn H, Roth A, Baker JL, Benn CS, Aaby P. Vaccinations against smallpox and tuberculosis are associated with better long-term survival: a Danish case-cohort study 1971-2010. Int J Epidemiol. 2016 Jul 5. PMCID: PMC5837789. Impact factor (2018): 8.360.

Andersen A, Rieckmann A. Using mi impute chained to fit ANCOVA models in randomized trials with censored dependent and independent variables. Stata Journal. StataCorp LP; 2016;16(3):650–661. Impact factor (2017/2018): 2.158.

PubMed link: https://www.ncbi.nlm.nih.gov/pubmed/?term=andreas+rieckmann